These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3293400)

  • 1. Primary prevention in patients with hypertension: comments on the clinical implications of the MAPHY Study. Metoprolol Atherosclerosis Prevention in Hypertensives Study.
    Wikstrand J
    Am Heart J; 1988 Jul; 116(1 Pt 2):338-47. PubMed ID: 3293400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY study.
    Wikstrand J; Warnold I; Olsson G; Tuomilehto J; Elmfeldt D; Berglund G
    JAMA; 1988 Apr; 259(13):1976-82. PubMed ID: 3346979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary prevention of sudden cardiovascular death in hypertensive patients. Mortality results from the MAPHY Study.
    Olsson G; Tuomilehto J; Berglund G; Elmfeldt D; Warnold I; Barber H; Eliasson K; Jastrup B; Karatzas N; Leer J
    Am J Hypertens; 1991 Feb; 4(2 Pt 1):151-8. PubMed ID: 2021446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased coronary heart disease in hypertensive smokers. Mortality results from the MAPHY study.
    Tuomilehto J; Wikstrand J; Olsson G; Elmfeldt D; Warnold I; Barber H; Eliasson K; Jastrup B; Karatzas N; Leer J
    Hypertension; 1989 Jun; 13(6 Pt 2):773-80. PubMed ID: 2737719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-blockers and diuretics. The HAPPHY and MAPHY studies.
    Berglund G
    Clin Exp Hypertens A; 1989; 11(5-6):1137-48. PubMed ID: 2571434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metoprolol versus thiazide diuretics in hypertension. Morbidity results from the MAPHY Study.
    Wikstrand J; Warnold I; Tuomilehto J; Olsson G; Barber HJ; Eliasson K; Elmfeldt D; Jastrup B; Karatzas NB; Leer J
    Hypertension; 1991 Apr; 17(4):579-88. PubMed ID: 2013485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary artery disease can be prevented by antihypertensive therapy: experiences from the MAPHY Study.
    Tuomilehto J; Wikstrand J; Warnold I; Olsson G; Elmfeldt D; Berglund G
    J Cardiovasc Pharmacol; 1990; 16 Suppl 7():S75-6. PubMed ID: 1708032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary prevention with beta-blockade in patients with hypertension: review of results and clinical implications.
    Wikstrand J
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S64-75. PubMed ID: 11527139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of antihypertensive treatment: metoprolol versus thiazide diuretics.
    Johannesson M; Wikstrand J; Jönsson B; Berglund G; Tuomilehto J
    Pharmacoeconomics; 1993 Jan; 3(1):36-44. PubMed ID: 10146986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metoprolol: a pharmacoeconomic and quality-of-life evaluation of its use in hypertension, post-myocardial infarction and dilated cardiomyopathy.
    Peters DH; Benfield P
    Pharmacoeconomics; 1994 Oct; 6(4):370-400. PubMed ID: 10147474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical comments on recent literature. SCRAAPHY about MAPHY from HAPPHY.
    Kaplan NM
    Am J Hypertens; 1988 Oct; 1(4 Pt 1):428-30. PubMed ID: 2905606
    [No Abstract]   [Full Text] [Related]  

  • 12. Thromboatherosclerotic complications in hypertensives: results of the Stockholm Metoprolol (secondary prevention) Trial.
    Olsson G
    Am Heart J; 1988 Jul; 116(1 Pt 2):334-8. PubMed ID: 3293399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QRS-amplitudes during antihypertensive treatment: a comparison between beta-blocker and thiazide diuretic regimens.
    Samuelsson O; Berglund G; Elmfeldt D; Wilhelmsen L; Wikstrand J
    Eur Heart J; 1986 Mar; 7(3):254-61. PubMed ID: 2940091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-blockade in the primary prevention of coronary heart disease in hypertensive patients. Review of present evidence.
    Wikstrand J; Berglund G; Tuomilehto J
    Circulation; 1991 Dec; 84(6 Suppl):VI93-100. PubMed ID: 1683615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-blockers and primary cardioprotection in hypertension.
    Fogari R; Zoppi A
    Drugs Exp Clin Res; 1990; 16(3):113-22. PubMed ID: 1974838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Confusing messages from the newest of the beta-blocker/diuretic hypertension trials. The Metoprolol Atherosclerosis Prevention in Hypertensives trial.
    Moser M; Sheps S
    Arch Intern Med; 1989 Oct; 149(10):2174-5. PubMed ID: 2572204
    [No Abstract]   [Full Text] [Related]  

  • 17. Factorial antihypertensive study of an extended-release metoprolol and hydrochlorothiazide combination.
    Papademetriou V; Hainer JW; Sugg J; Munzer D;
    Am J Hypertens; 2006 Dec; 19(12):1217-25. PubMed ID: 17161766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metoprolol in hypertension: an open evaluation.
    Assaykeen TA; Michell G
    Med J Aust; 1982 Jan; 1(2):73-7. PubMed ID: 7040924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effects of captopril and metoprolol on blood pressure and side effects in patients with mild to moderate hypertension].
    Kornerup HJ; Korsager S
    Ugeskr Laeger; 1989 Apr; 151(14):890-2. PubMed ID: 2652842
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.